Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 202Leukemia, Lymphocytic, Chronic, B-Cell 54Recurrence 37Neoplasms, Plasma Cell 30Lymphoma, Mantle-Cell 30Lymphoma 30Lymphoma, Follicular 29Lymphoma, Large B-Cell, Diffuse 27Leukemia 23Leukemia, Myeloid, Acute 22Lymphoma, Non-Hodgkin 21Lymphoma, B-Cell, Marginal Zone 15Myelodysplastic Syndromes 13Hodgkin Disease 12Waldenstrom Macroglobulinemia 8Prostatic Neoplasms 8Lymphoma, T-Cell 8Smoldering Multiple Myeloma 7Immunoglobulin Light-chain Amyloidosis 7Neoplasms 6Melanoma 6Lymphoma, B-Cell 6Hematologic Diseases 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Large-Cell, Anaplastic 5Leukemia, Myelomonocytic, Chronic 5Hematologic Neoplasms 5Amyloidosis 5Sezary Syndrome 4

Interventions

Doxorubicin 18Vincristine 15Zidovudine 11Bleomycin 11Cyclophosphamide 9Etoposide 8Interferon alpha-2 6Prednisone 5Cytarabine 5tecogalan 4sargramostim 4Rituximab 4Polymerase Chain Reaction 4Liposomes 4Filgrastim 4Dexamethasone 4Methotrexate 3Leucovorin 3Fluorouracil 3interferon alfa-n1 2Watchful Waiting 2Vinblastine 2Tumor Necrosis Factor-alpha 2Thalidomide 2Semaxinib 2Ritonavir 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Light Coagulation 2Isotretinoin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × HIV Infections × Lenalidomide × Clear all
NCT01057121 2022-02-08

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

National Cancer Institute (NCI)

Phase 1/2 Completed
38 enrolled 11 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡